focus -WSS

focus

author：focus 2025-10-01 17:19:33 - browse：36485

green electrocardiogram scan. -- health tech coverage from STAT — Adobe

As Bristol Myers Squibb works to build its treatment for a heart condition that can cause difficulty breathing into a blockbuster drug, it’s propped up an algorithm designed to help find more people who are affected.

The algorithm, which is part of software developed by Viz.ai, earlier this month received clearance from the Food and Drug Administration. The tool, called Viz HCM, looks at 12-lead electrocardiograms collected during routine care and flags suspected cases of hypertrophic cardiomyopathy, or HCM, for further evaluation. As part of a multi-year agreement between the companies, BMS — whose drug, Camzyos, is used to treat HCM — provided funding and scientific input for the development of the algorithm.

“BMS has a vested interest in finding more patients with HCM,” said Matthew Martinez, a cardiologist who leads Viz.ai’s HCM medical advisory board. “Why? Because they’re so philanthropic? No, they want to sell more drugs. They want to help more people by identifying more people.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Bernie Sanders is gearing up to subpoena pharma CEOs

WSS

Eli Lilly CEO gives to Mike Pence presidential super PAC

Zyn nicotine pouches become unlikely player in latest culture war

Why the drug industry's warnings on the IRA's impact fall short

Why Medicare shouldn’t cover every FDA

Free Covid tests will again be offered to all U.S. households

Readout Newsletter: Vertex, Pfizer, Kura, and other biotech news

focus

focus

explore

Medicare proposal to cover medical devices draws a mixed reaction

'A game

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

The Affordable Care Act has saved billions in health care costs

DIEP, the 'gold standard' of breast reconstruction, is under threat

Merck CEO won’t testify in Senate, citing no expertise in drug prices

Moonlake's readout produced a cash windfall. Risks remain

Zyn nicotine pouches become unlikely player in latest culture war

Activists slam private health insurers over coverage restrictions

Pancreatic cancer early detection could be helped by AI

Wikipedia

Information blocking fines are now fair game in health care

Why the quest to eradicate polio has stumbled

Assistant physicians can help address the primary care shortage

Bankrupt Pear's prescription app helped MassHealth save money, data suggests

Assistant physicians can help address the primary care shortage

White House pharmacy plagued with problems, investigation finds

leisure time

knowledge

explore

Wikipedia